Stocktoria
JOINT Corp JYNT
Nasdaq · XNAS · stock · Patent Owners & Lessors · website · IPO 2014-11-11
Chart by TradingView
4/9
Piotroski F — financial health
0.99
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $54.9M | $52.2M | $47.0M | $101.3M | $80.9M |
| Operating income | -$913,376 | -$1.9M | $318,299 | $828,254 | $5.4M |
| Net income | — | — | -$9.8M | $626,705 | $6.6M |
| Operating cash flow | $1.8M | $9.4M | $14.7M | $8.2M | $15.2M |
| Free cash flow | $334,724 | $8.2M | $9.7M | $2.3M | $8.2M |
| Total assets | $61.0M | $83.2M | $87.2M | $93.5M | $85.5M |
| Total liabilities | $45.9M | $62.5M | $62.4M | $60.9M | $55.9M |
| Shareholders' equity | $15.1M | $20.7M | $24.8M | $32.6M | $30.3M |
| Ratios | |||||
| Operating margin | -1.7% | -3.6% | 0.7% | 0.8% | 6.6% |
| Net margin | — | — | -20.8% | 0.6% | 8.1% |
| FCF margin | 0.6% | 15.8% | 20.6% | 2.3% | 10.2% |
| Return on assets | — | — | -11.2% | 0.7% | 7.7% |
| Return on equity | — | — | -39.4% | 1.9% | 21.7% |
| Current ratio | 1.59 | 1.52 | 1.32 | 0.76 | 1.25 |
| Revenue growth | 5.2% | 11.0% | -53.6% | 25.2% | 37.8% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 228,578 | $2.0M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.99 (distress)
- Working capital / assets 0.316
- Retained earnings / assets -0.407
- EBIT / assets -0.015
- Equity / liabilities 0.328
Sector peers
IX · MUFG · MFG · NMR · UNH · CI · all Finance, Insurance & Real Estate →
Source: SEC EDGAR filings · CIK 0001612630 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.